Black Diamond Therapeutic (BDTX) Stock Price, Quote, News & History | Benzinga

Black Diamond Therapeutics Inc (BDTX) Stock Price, Quote, News & History

BDTXNASDAQ

Trade with Public

Trade with Public

$2.19

0.136.31%

Last update: Aug 19, 3:38 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$2.09

Close

-

Volume / Avg.

700.59K / 1.62M

Day Range

$2.08 - $2.21

52 Wk Range

1.60 - 4.94

Market Cap

$125.49M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

68

Short Interest

14.72%

Days to Cover

8.7

Recent Black Diamond Therapeutics Inc News

What's Going On With Black Diamond Therapeutics Stock Tuesday?

Black Diamond Therapeutics (NASDAQ: BDTX) stock climbs. Get the latest technical analysis, moving averages, and price action.

Lekha Gupta

This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Avi Kapoor

Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data

Black Diamond posts strong Phase 2 lung cancer results with a 60% response rate and solid safety profile while preparing major trial updates and GBM expansion plans.

Vandana Singh

US Stocks Mixed; Dollar Tree Posts Upbeat Earnings

Avi Kapoor

4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals

4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-32.84M

Investing Cash Flow (TTM)

22.08M

Financing Cash Flow (TTM)

-30.00K

Free Cash Flow (TTM)

-32.84M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-10.79M

Analyst Trends and Forecast

1

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$24.82M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.23

Earnings Yield % (TTM)

-36.41%

Earnings Yield % (FWD)

-36.41%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.67

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$19.19M

Debt to Equity

0.18

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$2.09

Close

-

Volume / Avg.

700.59K / 1.62M

Day Range

$2.08 - $2.21

52 Wk Range

1.60 - 4.94

Market Cap

$125.49M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

68

Short Interest

14.72%

Days to Cover

8.7

About

Sector

Health Care

Industry

Biotechnology

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer gen...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Black Diamond Therapeutic (BDTX) stock?

A

You can purchase shares of Black Diamond Therapeutic (NASDAQ:BDTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Black Diamond Therapeutic (BDTX) competitors?

A

Other companies in Black Diamond Therapeutic’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Black Diamond Therapeutic (BDTX) stock?

A

Black Diamond Therapeutic has a consensus price target of $11.80.

Q

What is the current price for Black Diamond Therapeutic (BDTX)?

A

The stock price for Black Diamond Therapeutic (NASDAQ: BDTX) is $2.19 last updated August 19, 2026 at 3:38 PM EDT.

Q

Does Black Diamond Therapeutic (BDTX) pay a dividend?

A

There are no upcoming dividends for Black Diamond Therapeutic.

Q

When is Black Diamond Therapeutic (NASDAQ:BDTX) reporting earnings?

A

Black Diamond Therapeutic does not have any upcoming earnings scheduled.

Q

Is Black Diamond Therapeutic (BDTX) going to split?

A

There is no upcoming split for Black Diamond Therapeutic.

Q

What sector and industry does Black Diamond Therapeutic (BDTX) operate in?

A

Black Diamond Therapeutic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.